Induced sputum in systemic sclerosis interstitial lung disease: Comparison to healthy controls and bronchoalveolar lavage

Respiration

Volumn 78, Issue 1, 2009, Pages 56-62

  Damjanov, N ^a   Ostojic, P ^a   Kaloudi, O ^d   Alari, S ^d   Guiducci, S ^d   Stanflin, N ^e   Nestorovic, B ^b   Knezevic, J ^c   Camiciottoli, G ^f   Porta, F ^d   Pistolesi, M ^f   Ibba Manneschi, L ^g   Conforti, M L ^d   Candelieri, A ^h   Matucci Cerinic, M ^d  

^a University of Belgrade   (Italy)

^b Child Clinic   (Italy)

^c Belmedic General Hospital   (Serbia)

^d Centre Denothe   (Italy)

^e Departments of Pneumology   (Italy)

^f Pathophysiology and Department of Anatomy   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Bronchoalveolar lavage; Induced sputum; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SAFETY; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; SYSTEMIC SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SPUTUM;

EID: 67749114466     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000164720     Document Type: Article

References (33)

1. D'Angelo WA, Fries JF, Masi AT, Shulman LE: Pathologic observations in systemic sclerosis (scleroderma): a study of 58 autopsy cases and 58 matched controls. Am J Med 1969; 46: 428-437.
2. Simeon CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C, et al: Survival prognostic factors and markers of mor-bidit y in Spanish patients with systemic sclerosis. Ann Rheum Dis 1997; 56: 723-728.
3. Hesselstrand R, Scheja A, Akesson A: Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57:682-686.
4. Cossio M, Menon Y, Wilson W, deBoisblanc BP: Life-threatening complications of systemic sclerosis. Crit Care Clin 2002; 18:819- 839.
5. Warrick JH, Balla M, Schalbel SI, et al: High resolution computer tomography in early lung disease. J R heumatol 1991; 18: 1520 - 1528.
6. Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, et al: High resolution computer tomography as predictor of lung histology in systemic sclerosis. Thorax 1992; 11: 465-472.
7. Silver RM, Miller KS, Smith EA, Schabel SI: Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. A m J Med 1990; 88: 470-476.
8. Witt C, Borgess AC, John M, et al: Pulmonary involvement in diffuse cutaneous systemic sclerosis: bronchoalveolar fluid gran-ulocytosis predicts progression of fibrosing alveolitis. Ann Rheum Dis 1999; 58: 635- 640.
9. Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, Black CM, du Bois RM, Wells AU: Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 2007; 56:2005-2012.
10. Vatrella A, Bocchino M, Perna F, Scarpa R, Galati D, Spina S, Pelaia G, Cazzola M, San-duzzi A: Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement Respir Med 2007; 101:1383-1389.
11. LeRoy EC, Black C, Fleischmajer R, Jablon-ska S, Krieg T, Medsger TA Jr, et al: Sclero-derma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
12. Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN: Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165: 731-734.
13. Wells AU, Rubens MB, du Bois RM, Hansell DM: Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol 1993; 161: 1159 -1165.
14. Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir J 2005; 26:319 -338.
15. Wanger J, Clausen JL, Coates A, et al: Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26:511-522.
16. Macintyre N, Crapo RO, Viegi G, et al: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720 -735.
17. Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE: Indices of airway inflammation in induced sputum: re-producibility and validity of cell fluid-phase measurements. Am J Respir Crit Care Med 19 96; 154: 308-317.
18. Spanevello A, Migliori GB, Sharara AM, Bal-lardin L, Bridge P, Pisati P, Neri M, Ind PW: Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Al-lergy 1997; 27: 1138 -1144.
19. In't Veen JCCM, De Gouw HWFM, Smits HH, Sont JK, Hiemstra PS, Sterk PJ, Bel EH: Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996; 9: 2441-2447.
20. Confalonieri M, Mainardi E, Della Porta R, Bernorio S, Gandola L, Beghè B, Spanevello A: Inhaled corticosteroids reduce neutro-philic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53:583-585.
21. Spanevello A, Beghè B, Bianchi A, Migliori GB, Ambrosetti M, Neri M, Ind PW: Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med 1988; 157: 665-668.
22. Brightling C: Clinical application of induced sputum. Chest 2006; 129:1344-1348.
23. Fireman E, Lerman Y: Induced sputum in in-terstitiallung diseases. Curr Opin Pulm Med 2006; 12:318 -322.
24. Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori GB, et al: Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2002; 162:1172-1174.
25. Belda J, Leigh R, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE: Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161:475-478.
26. Stanescu D, Sanna A, Veriter C, et al: Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thora x 1996; 51: 267-271.
27. D'Ippolito R, Foresi A, Chetta A, Casalini A, Castagnaro A, Leone C, Olivieri D: Induced sputum in patients with newly diagnosed sarcoidosis. Chest 1999; 115: 1611-1615.
28. Behr J, Vogelmeier C, Beinert T, Meurer M, Krombach F, König G, Fruhmann G: Bron-choalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 1996; 154: 400- 406.
29. Ettensohn DB, Jankowski MJ, Redondo AA, Duncan PG: Bronchoalveolar lavage in the normal volunteer subject. 2. Safety and results of repeated BAL, and use in the assessment of intrasubject variability. Chest 1988; 94:281-285.
30. Fireman E, Topilsky I, Greif J, Lerman Y, Schwarz Y, Man A, Topilsky M: Induced sputum compared to bronchoalveloar lavage for evaluating patients with sarcoidosis and nongranulomatous interstitial lung disease. Respir Med 1999; 93:827-834.
31. Fireman E, Grief J, Schwarz Y: Assessment of hazardous dust exposure by BAL and induced sputum. Chest 1999; 115:1720-1728.
32. Gravelyn TR, Pan PM, Eschenbacher WL: Mediator release in an isolated airway segment in subjects with asthma. Am Rev Respir Dis 1988; 137: 641- 646.
33. Makker HK, Holgate ST: The contribution of neurogenic reflexes to hypertonic saline induced bronchoconstriction in asthma. J Allergy Clin Immunol 1993; 92:82- 88.